Introduction {#ss1}
============

Overweight and obesity are common health conditions and their prevalence is increasing globally[^1--3^](#b1 b2 b3){ref-type="ref"}. Excess weight is well‐known to be associated with an increased risk of diabetes, hypertension, dyslipidemia and cardiovascular disease, and recent studies have reported that it might also be a risk factor for microvascular disease[^4--6^](#b4 b5 b6){ref-type="ref"}, including retinal vasculature[^7,8^](#b7 b8){ref-type="ref"}. Although many studies have investigated the risk factors associated with the development of obesity[^9--12^](#b9 b10 b11 b12){ref-type="ref"}, to predict the risk factors of developing obesity remains challenging.

Population‐based studies have shown that retinal vascular changes are associated with the subsequent development of systemic diseases, such as diabetes[^13,14^](#b13 b14){ref-type="ref"} and hypertension[^15--19^](#b15 b16 b17 b18 b19){ref-type="ref"}. Researchers have hypothesized that retinal microvascular changes might be antecedent of developing obesity based on experimental and clinical observations[^4,20,21^](#b4 b20 b21){ref-type="ref"}. For example, in the Blue Mountains Eye Study (BMES), retinal vessel diameters were not only associated with the prevalence of higher body mass index (BMI), but also with an increased risk of incident obesity[^22^](#b22){ref-type="ref"}.

However, it is unclear whether the association observed in Caucasian populations is consistently observed in other racial/ethnic groups, because the level of obesity is known to be highly dependent on race/ethnicity[^23^](#b23){ref-type="ref"}. For example, it was reported that Asian populations have a different degree of association between obesity and cardiovascular diseases compared with Caucasian populations[^24^](#b24){ref-type="ref"}. Therefore, we aimed to examine the association between retinal vessel caliber and prevalence, and 5‐year incidence of obesity and overweight in an adult Japanese population of the Funagata study.

Materials and Methods {#ss2}
=====================

Study Population {#ss3}
----------------

The Funagata study is a population‐based study examining the risk factors and complications of diabetes in adult Japanese aged 35 years or older[^25--27^](#b25 b26 b27){ref-type="ref"}. The study population and research methodology has been described elsewhere[^28^](#b28){ref-type="ref"}. Written consent was obtained from all study participants, and the study was carried out according to the recommendations of the Declaration of Helsinki and approved by the Ethics Committee of the Yamagata University Faculty of Medicine, Yamagata, Japan.

In 2000--2002, 1786 subjects underwent systemic and retinal examinations (baseline examinations); 900 (50.4%) of these subjects underwent an assessment for obesity or overweight and had quality fundus photographs taken for the measurement of retinal vessels, and were included in an analysis of the association between retinal vessel caliber and the prevalence of obesity. Of these, 584 subjects were not obese. In 2005--2007, 454 (52.9%) subjects returned for a follow‐up examination and were included in the current analysis of the association between retinal vessel caliber and 5‐year incidence of obesity.

Assessments of Retinal Vessel Caliber {#ss4}
-------------------------------------

All fundus photographs were taken using a 45° non‐mydriatic fundus camera (CR5‐NM45; Canon, Tokyo, Japan; and TRC; Topcon, Tokyo, Japan). The arteriolar and venular diameters were assessed at the Fundus Reading Center (Center for Vision Research, University of Sydney, Sydney, Australia) using semi‐automated computer‐assisted imaging software (developed by the University of Wisconsin, Madison, WI, USA). Details of image preparation and grading protocol have been described previously.[^28^](#b28){ref-type="ref"} In brief, a single field fundus photograph of the right eye was examined for retinal vessel caliber measurement. Magnification percentage was calculated based on resolution of images. Then a trained grader identified all arterioles and venules crossing through the circular zone between half of the optic disc diameter and one optic disc diameter from the optic disc margin. The software automatically measured and calculated the caliber of arterioles and venules separately. These measurements were summarized using the modified Parr--Hubbard formula[^29^](#b29){ref-type="ref"} as the central retinal artery equivalent (CRAE) and central retinal vein equivalent (CRVE), respectively.

Assessment of Systemic Characteristics {#ss5}
--------------------------------------

At the baseline examinations, serum total cholesterol, high‐density lipoprotein (HDL) cholesterol and triglyceride levels, as well as plasma glucose concentration, were measured in fasting blood samples. BMI was calculated as weight (kg) divided by the square of the height (m). Waist and hip circumferences were measured in all subjects in a relaxed standing position wearing underclothes only by specially trained observers. Waist circumference was measured to the nearest 1 cm at the level of the umbilicus. Hip circumference was measured to the nearest 1 cm at the level of the greatest girth. Waist‐to‐hip ratio (WHR) was calculated as waist circumference divided by hip circumference. Body fat percentage was measured by bioelectrical impedance analysis (TBF‐101; Tanita, Tokyo, Japan).

Definition of Obese and Overweight {#ss6}
----------------------------------

The definition of obese and overweight in the present study were based on BMI criteria for Asians by the regional office for the Western Pacific Region of WHO (WRPRO criteria, 2000)[^30^](#b30){ref-type="ref"} and the guideline proposed by the Japan Society for the study of Obesity[^31^](#b31){ref-type="ref"}; the BMI cut‐off value was BMI ≥ 23 kg/m^2^, but \<25 kg/m^2^ for overweight and BMI ≥ 25 kg/m^2^ for obese. *Incidence of overweight* was defined as not overweight or obese at baseline examinations, but overweight or obese at follow up, and *incidence of obesity* was defined as not obese at baseline examinations, but obese at follow up.

We also used two definitions of central obesity based on the 2006 International Diabetes Federation (IDF) definition and its updated definition as follows: (i) waist circumference cut‐off values of ≥85 cm for men and ≥90 cm for women; and (ii) waist circumference cut‐off values of ≥90 cm for men and ≥80 cm for women. *Incidence of central obesity* was defined as no central obesity at baseline examinations, but central obesity at follow up.

High WHR was defined as \>0.90 for men and \>0.85 for women according to the WHO definition of metabolic syndrome[^32^](#b32){ref-type="ref"}. *Incidence of increased WHR* was defined as the absence of high WHR at baseline examinations, but its presence at follow up. A high body fat percentage was defined as ≥25% for men and ≥30% for women from a report on Japanese subjects[^33^](#b33){ref-type="ref"}. *Incidence of increased body fat percentage* was defined as the absence of high body fat percentage at baseline examinations, but its presence at follow up.

Statistical Analysis {#ss7}
--------------------

Statistical analysis software [spss]{.smallcaps} 14.0 (SPSS, Chicago, IL, USA) was used for data analysis. We compared baseline characteristics between subjects who were included in this analysis and those who were lost to follow up. We compared clinical characteristics between overweight or obese subjects and non‐overweight subjects by Student's *t*‐test or Mann--Whitney *U*‐test, and a χ^2^‐test as appropriate. To examine whether retinal vessel caliber were associated with measures of obesity, multiple logistic regression analysis was carried out to estimate the odds ratios (OR) of outcomes (i.e. overweight, obesity, high WHR and high body fat percentage) per standard deviation (SD) change in retinal vessel caliber after initial adjustment for age and gender, and then additional adjustment for smoking status, mean arterial blood pressure (MABP; calculated as \[MABP\] = \[1/3 × SBP\] + \[2/3 × DBP\], where SBP = systolic blood pressure and DBP = diastolic blood pressure), serum total cholesterol, triglycerides and fasting plasma glucose. CRAE and CRVE were simultaneously included in the multivariate models as independent variables as recommended[^34^](#b34){ref-type="ref"}. *P*‐values \<0.05 were considered statistically significant.

Results {#ss8}
=======

Cross‐sectional Association of Retinal Vessel Caliber and Measures of Obesity {#ss9}
-----------------------------------------------------------------------------

A comparison of baseline characteristics between subjects who were included in the present study is given in [Table 1](#t1){ref-type="table-wrap"}. Significant differences were observed for age, SBP, height, bodyweight, BMI, waist and hip circumferences, fasting plasma glucose, and smoking status.

######  Baseline and 5‐year follow‐up characteristics of the study subjects

  Clinical characteristics                       Included\* (*n* = 900)         Excluded (*n* = 886)   *P*‐value                      Non‐overweight† and obesity subjects at baseline examinations (*n* = 382)   *P‐*value      
  ---------------------------------------------- ------------------------------ ---------------------- ------------------------------ --------------------------------------------------------------------------- -------------- -------
  Age (years)                                    58.5 ± 11.7                    63.4 ± 12.2            \<0.001                        56.1 ± 11.1                                                                 59.6 ± 13.4    0.006
  Systolic blood pressure (mmHg)                 126.3 ± 16.9                   128.8 ± 16.9           \<0.001                        120.4 ± 15.5                                                                123.9 ± 16.7   0.024
  Diastolic blood pressure (mmHg)                75.6 ± 10.1                    76.2 ± 9.9             0.246                          72.2 ± 9.5                                                                  73.2 ± 10.4    0.289
  Height (cm)                                    156.1 ± 8.7                    153.6 ± 10.9           \<0.001                        156.3 ± 8.4                                                                 155.5 ± 8.3    0.415
  Bodyweight (kg)                                58.5 ± 10.6                    56.0 ± 10.6            \<0.001                        51.5 ± 6.9                                                                  50.4 ± 7.0     0.12
  Body mass index (kg/m^2^)                      23.9 ± 3.4                     23.6 ± 3.6             0.028                          21.0 ± 1.6                                                                  20.7 ± 1.7     0.255
  Waist circumference (cm)                       79.0 ± 9.5                     77.5 ± 9.3             0.001                          72.0 ± 6.5                                                                  72.6 ± 7.6     0.587
  Hip circumference (cm)                         92.9 ± 6.5                     91.4 ± 6.2             \<0.001                        88.4 ± 4.3                                                                  88.2 ± 4.8     0.608
  Waist‐to‐hip ratio                             0.85 ± 0.07                    0.85 ± 0.07            0.429                          0.81 ± 0.59                                                                 0.82 ± 0.06    0.294
  Body fat percentage (%)                        25.4 ± 7.2                     25.0 ± 8.1             0.212                          21.3 ± 5.0                                                                  20.3 ± 5.3     0.199
  Serum total cholesterol (mg/dL)                201.0 ± 33.0                   202.3 ± 34.4           0.404                          198.2 ± 34.3                                                                194.0 ± 32.2   0.282
  High‐density lipoprotein cholesterol (mg/dL)   58.6 ± 14.3                    58.3 ± 14.8            0.65                           62.9 ± 13.6                                                                 63.7 ± 13.8    0.413
  Triglycerides (mg/dL)                          117.0 ± 133.8                  121.2 ± 115.4          0.47                           96.4 ± 64.2                                                                 90.7 ± 45.4    0.814
                                                 Median (interquartile range)                          Median (interquartile range)                                                                                              
  Fasting plasma glucose (mg/dL)                  92 (87, 101)                   94 (88, 101)          0.009                           89 (85, 94)                                                                91 (86, 98)    0.009
                                                 *n* (%)                                               *n* (%)                                                                                                                   
  Males                                          388 (43.1)                     397 (44.8)             0.47                            77 (38.9)                                                                  80 (43.5)      0.265
  Current smoker                                 167 (18.8)                     148 (16.9)             0.029                           37 (18.8)                                                                  46 (25.7)      0.444
  Past smoker                                    135 (15.2)                     102 (11.6)              28 (14.2)                     22 (12.3)                                                                                  
  Never smoked                                   586 (66.0)                     627 (71.5)             132 (67.0)                     111 (62.0)                                                                                 

\*Data of body mass index and retinal vessel diameters were available. †Overweight was defined as a body mass index ≥ 23 kg/m^2^ but \<25 kg/m^2^.

Cross‐sectional associations between baseline retinal vessel calibers and measures of obesity are given in [Table 2](#t2){ref-type="table-wrap"}. Of the 900 subjects, 316 (35.1%) and 202 (22.4%) were obese and overweight, respectively. Subjects with wider retinal venular caliber were more likely to be obese (OR per 1 SD increase in CRVE: 1.16; 95% CI 1.01--1.33; *P* = 0.04) and overweight (OR per 1 SD increase in CRVE: 1.22; 95% CI 1.07--1.39; *P* = 0.003). This association remained significant after adjustment for age and sex. However, in a multivariable‐adjusted model, wider retinal venular caliber was not significantly associated with the prevalence of overweight (OR per 1 SD increase in CRVE: 1.17; 95% CI 0.98--1.41; *P* = 0.087) or obesity (OR per 1 SD increase in CRVE: 1.16; 95% CI 0.96--1.41; *P* = 0.127). Wider retinal venular caliber was significantly associated with high WHR (OR per 1 SD increase in CRVE: 1.25; 95% CI 1.03--1.51; *P* = 0.023) and central obesity according to the 2006 IDF definition (OR per 1 SD increase in CRVE: 1.40; 95% CI 1.09--1.78; *P* = 0.007) or the updated IDF definition (OR per 1 SD increase in CRVE: 1.39; 95% CI 1.13--1.71; *P* = 0.002) even after fully adjusted. The prevalence of high body fat percentage was not associated with either retinal arteriolar or venular caliber.

######  Associations between retinal vessel calibers and various indices of the prevalence of obesity in the Funagata study population

  Indices of obesity                                                            *n*   Affected (%)   Odds ratio (95% confidence interval)                                                                             
  ----------------------------------------------------------------------------- ----- -------------- -------------------------------------- --------- --------------------------- ------- --------------------------- -------
  Per 1 SD decrease in central retinal artery equivalent                                                                                                                                                              
   Obesity (BMI ≥ 25 kg/m^2^)                                                   900   316 (35.1)     0.99 (0.85--1.14)                                0.98 (0.85--1.12)                   0.99 (0.82--1.20)            
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                                    900   518 (57.6)     0.92 (0.81--1.05)                                0.90 (0.79--1.03)                   0.93 (0.77--1.12)            
   High waist hip ratio (WHR \> 0.90 for men, \>0.85 for women)                 883   308 (34.9)     1.07 (0.93--1.23)                                0.98 (0.85--1.14)                   1.08 (0.89--1.31)            
   Central obesity (2006 IDF definition; 85 cm for men, ≥90 cm for women)       883   197 (22.3)     0.97 (0.82--1.13)                                0.93 (0.77--1.11)                   1.10 (0.87--1.40)            
   Central obesity (updated IDF definition; ≥90 cm for men, ≥80 cm for women)   883   242 (27.4)     1.00 (0.86--1.16)                                0.95 (0.81--1.10)                   1.09 (0.89--1.33)            
   High body fat percentage (≥25% for men, ≥30% for women)                      901   324 (36.0)     1.02 (0.89--1.17)                                1.02 (0.89--1.17)                   1.07 (0.89--1.29)            
  Per 1 SD increase of central retinal vein equivalent                                                                                                                                                                
   Obesity (BMI ≥ 25 kg/m^2^)                                                   900   316 (35.1)     **1.16** (**1.01--1.33**)              0.04      **1.18** (**1.02--1.35**)   0.024   1.16 (0.96--1.41)            
  Overweight and obesity (BMI ≥ 23 kg/m^2^)                                     900   518 (57.6)     **1.22** (**1.07--1.39**)              0.003     **1.24** (**1.08--1.42**)   0.002   1.17 (0.98--1.41)            
   High waist‐to‐hip ratio (WHR \> 0.90 for men, \>0.85 for women)              883   308 (34.9)     1.13 (0.98--1.30)                                **1.21** (**1.04--1.40**)   0.011   **1.25** (**1.03--1.51**)   0.023
   Central obesity (2006 IDF definition; ≥85 cm for men, ≥90 cm or women)       883   197 (22.3)     **1.37** (**1.16--1.62**)              \<0.001   **1.34** (**1.12--1.61**)   0.002   **1.40** (**1.09--1.78**)   0.007
   Central obesity (updated IDF definition; ≥90 cm for men, ≥80 cm for women)   883   242 (27.4)     **1.22** (**1.05--1.42**)              0.011     **1.32** (**1.13--1.54**)   0.001   **1.39** (**1.13--1.71**)   0.002
   High body fat percentage (≥25% for men, ≥30% for women)                      901   324 (36.0)     1.11 (0.96--1.27)                                1.15 (0.99--1.32)                   1.17 (0.97--1.41)            

BMI, body mass index; IDF, International Diabetes Federation; WHR, waist‐to‐hip ratio. \*Multivariable‐adjusted model: adjusted for age, sex, smoking status, mean arterial blood pressure, total plasma cholesterol, triglycerides and fasting plasma glucose.

Cross‐sectional associations between baseline retinal vessel calibers and measures of obesity stratified by sex are shown in [Table 3](#t3){ref-type="table-wrap"}. Female subjects with narrower retinal arteriolar caliber were less likely to be overweight (OR per 1 SD decrease in CRAE: 0.84; 95% CI 0.70--0.99; *P* = 0.048), and subjects with wider retinal venular caliber were more likely to be obese (OR per 1 SD increase in CRVE: 1.21; 95% CI 1.01--1.46; *P* = 0.04) or overweight (OR per 1 SD increase in CRVE: 1.29; 95% CI 1.09--1.54; *P* = 0.003) after adjusting for age.

######  Associations between retinal vessel calibers and various indices of the prevalence of obesity in the Funagata study population by sex

  Indices of obesity                                         *n*   Affected (%)   Odds ratio (95% confidence interval)                                               
  ---------------------------------------------------------- ----- -------------- -------------------------------------- ------- --------------------------- ------- -------------------
  *Per 1 SD decrease in central retinal artery equivalent*                                                                                                           
  Male                                                                                                                                                               
   Obesity (BMI ≥ 25 kg/m^2^)                                388   134 (34.5)     0.93 (0.75--1.16)                              0.96 (0.77--1.20)                   1.06 (0.78--1.44)
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                 388   231 (59.5)     0.96 (0.78--1.18)                              0.98 (0.79--1.21)                   1.02 (0.75--1.38)
  Female                                                                                                                                                             
   Obesity (BMI ≥ 25 kg/m^2^)                                512   182 (35.5)     1.03 (0.86--1.23)                              0.96 (0.80--1.15)                   1.04 (0.81--1.32)
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                 512   287 (56.1)     0.89 (0.75--1.06)                      ** **   **0.84** (**0.70--0.99**)   0.048   0.86 (0.67--1.09)
  *Per 1 SD increase of central retinal vein equivalent*                                                                                                             
  Male                                                                                                                                                               
   Obesity (BMI ≥ 25 kg/m^2^)                                388   134 (34.5)     1.16 (0.93--1.45)                              1.13 (0.90--1.41)                   1.07 (0.78--1.48)
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                 388   231 (59.5)     1.10 (0.89--1.37)                              1.08 (0.87--1.34)                   1.04 (0.77--1.41)
  Female                                                                                                                                                             
   Obesity (BMI ≥ 25 kg/m^2^)                                512   182 (35.5)     1.15 (0.96--1.37)                      ** **   **1.21** (**1.01--1.46**)   0.04    1.24 (0.98--1.58)
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                 512   287 (56.1)     **1.29** (**1.09--1.54**)              0.003   **1.35** (**1.13--1.62**)   0.001   1.26 (0.99--1.59)

BMI, body mass index. \*Multivariable‐adjusted model: adjusted for age, sex, smoking status, mean arterial blood pressure, total plasma cholesterol, triglycerides and fasting plasma glucose.

Longitudinal Association between Retinal Vessel Caliber and Incidence of Obesity {#ss10}
--------------------------------------------------------------------------------

Comparison of clinical characteristic between subjects who returned for follow‐up examination and those who were lost to follow‐up is given in [Table 1](#t1){ref-type="table-wrap"}. Subjects who returned for the follow‐up examination were significantly younger (56.1 *vs* 59.6 years; *P* = 0.006), had lower SBP (120.4 *vs* 123.9 mmHg; *P* = 0.024), and had lower fasting plasma glucose (89 *vs* 91 mg/dL; *P* = 0.009). The associations between baseline retinal vessel caliber and incidence of overweight or obesity are given in [Table 4](#t4){ref-type="table-wrap"}. Although narrower retinal arteriolar and wider venular caliber seems to have higher odds of incident obesity (point estimated of adjusted OR per 1 SD decrease in CRAE and per 1 SD increase in CRVE: 1.21 and 1.37, respectively) and overweight (point estimated of adjusted OR per 1SD decrease in CRAE and per 1SD increase in CRVE: 1.04 and 1.39, respectively), these associations were not statistically significant.

######  Associations between retinal vessel diameters and various indices of incident obesity in the Funagata study population

  Indices of obesity                                                            *n*   Affected (%)   Odds ratio (95% confidence interval)                       
  ----------------------------------------------------------------------------- ----- -------------- -------------------------------------- ------------------- -------------------
  Per 1 SD decrease of central retinal artery equivalent                                                                                                        
   Obesity (BMI ≥ 25 kg/m^2^)                                                   303   32 (10.6)      0.99 (0.68--1.42)                      0.97 (0.67--1.41)   1.21 (0.74--2.00)
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                                    198   30 (15.2)      0.89 (0.61--1.31)                      0.89 (0.59--1.32)   1.04 (0.59--1.84)
   High waist hip ratio (WHR \> 0.90 for men, \>0.85 for women)                 322   125 (38.8)     1.06 (0.85--1.33)                      1.03 (0.82--1.30)   1.20 (0.89--1.61)
   Central obesity (2006 IDF definition; ≥85 cm for men, ≥90 cm for women)      368   45 (12.2)      1.05 (0.77--1.43)                      0.97 (0.70--1.34)   0.86 (0.56--1.33)
   Central obesity (updated IDF definition; ≥90 cm for men, ≥80 cm for women)   351   63 (17.9)      0.99 (0.76--1.31)                      0.99 (0.74--1.31)   1.00 (0.70--1.43)
   High body fat percentage (≥25% for men, ≥30% for women)                      305   44 (14.4)      0.91 (0.66--1.25)                      0.94 (0.68--1.31)   0.93 (0.60--1.42)
  Per 1 SD increase in central retinal vein equivalent                                                                                                          
   Obesity (BMI ≥ 25 kg/m^2^)                                                   303   32 (10.6)      1.25 (0.87--1.81)                      1.25 (0.86--1.82)   1.37 (0.85--2.23)
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                                    198   30 (15.2)      1.34 (0.90--2.01)                      1.37 (0.91--2.16)   1.39 (0.78--2.49)
   High waist‐to‐hip ratio (WHR \> 0.90 for men, \>0.85 for women)              322   125 (38.8)     1.15 (0.92--1.44)                      1.19 (0.95--1.51)   1.29 (0.95--1.74)
   Central obesity (2006 IDF definition; ≥85 cm for men, ≥90 cm for women)      368   45 (12.2)      0.92 (0.67--1.25)                      0.92 (0.66--1.27)   0.75 (0.49--1.16)
   Central obesity (updated IDF definition; ≥90 cm for men, ≥80 cm for women)   351   63 (17.9)      0.99 (0.76--1.30)                      1.07 (0.81--1.41)   1.00 (0.70--1.43)
   High body fat percentage (≥25% for men, ≥30% for women)                      305   44 (14.4)      1.10 (0.80--1.51)                      1.10 (0.80--1.51)   1.04 (0.69--1.58)

\*Multivariable‐adjusted model: adjusted for age, sex, smoking status, mean arterial blood pressure, total plasma cholesterol, triglycerides and fasting plasma glucose. BMI, body mass index; IDF, International Diabetes Federation; WHR, waist‐to‐hip ratio.

The associations between baseline retinal vessel caliber and incidence of overweight or obesity by sex are given in [Table 5](#t5){ref-type="table-wrap"}. Female subjects with wider retinal venular caliber had a twofold higher risk of incident obesity over 5 years (OR per 1 SD increase in CRVE: 2.10; 95% CI 1.08--4.06; *P* = 0.028) after fully adjusted for potential confounding factors, and there was a significant association with incident overweight (OR per 1 SD increase in CRVE: 1.71; 95% CI 1.01--2.86; *P* = 0.043).

######  Associations between retinal vessel diameters and various indices of incident obesity in the Funagata study population by sex

  Indices of obesity                                         *n*   Affected (%)   Odds ratio (95% confidence interval)                                                                           
  ---------------------------------------------------------- ----- -------------- -------------------------------------- ------- --------------------------- ------- --------------------------- -------
  *Per 1 SD decrease in central retinal artery equivalent*                                                                                                                                       
  Male                                                                                                                                                                                           
   Obesity (BMI ≥ 25 kg/m^2^)                                130   15 (11.5)      1.02 (0.57--1.81)                              1.01 (0.56--1.81)                   0.98 (0.44--2.18)            
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                 77    11 (14.3)      1.19 (0.61--2.33)                              1.36 (0.6--2.73)                    1.40 (0.54, 3.63)            
  Female                                                                                                                                                                                         
   Obesity (BMI ≥ 25 kg/m^2^)                                173   17 (9.82)      0.94 (0.58--1.53)                              0.94 (0.57--1.54)                   1.48 (0.76--2.86)            
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                 121   19 (15.7)      0.76 (0.46--1.25)                              0.69 (0.41--1.16)                   0.73 (0.33--1.59)            
  *Per 1 SD increase of central retinal vein equivalent*                                                                                                                                         
  Male                                                                                                                                                                                           
   Obesity (BMI ≥ 25 kg/m^2^)                                130   15 (11.5)      0.91 (0.51--1.64)                              0.91 (0.51--1.65)                   0.82 (0.38--1.74)            
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                 77    11 (14.3)      0.86 (0.43--1.75)                              0.82 (0.42--1.63)                   1.13 (0.44--2.91)            
  Female                                                                                                                                                                                         
   Obesity (BMI ≥ 25 kg/m^2^)                                173   17 (9.82)      1.56 (0.95--2.56)                              1.56 (0.94--2.57)                   **2.10** (**1.08--4.06**)   0.028
   Overweight and obesity (BMI ≥ 23 kg/m^2^)                 121   19 (15.7)      **1.71** (**1.01--2.86**)              0.043   **1.86** (**1.07--3.24**)   0.027   1.81 (0.85--3.85)            

BMI, body mass index. \*Multivariable‐adjusted model: adjusted for age, sex, smoking status, mean arterial blood pressure, total plasma cholesterol, triglycerides and fasting plasma glucose.

Discussion {#ss11}
==========

In this adult Japanese population, we confirmed positive cross‐sectional associations between retinal venular dilation and overweight subjects, and between high WHR and central obesity, independent of age and sex. The association between retinal venular dilation and high WHR was significant after multivariate adjustment for smoking, blood pressure, lipids and fasting plasma glucose, whereas it was attenuated for overweight and obesity. Previous population‐based studies mainly on Caucasian populations including the BMES[^22^](#b22){ref-type="ref"}, Rotterdam Study[^21^](#b21){ref-type="ref"} and ARIC Study[^8^](#b8){ref-type="ref"} showed positive cross‐sectional associations between wider retinal venular caliber and obesity defined by greater waist circumference[^8^](#b8){ref-type="ref"}, WHR[^21^](#b21){ref-type="ref"} and BMI[^22,35^](#b22 b35){ref-type="ref"}. Our previous study also found that wider retinal caliber was related to metabolic syndrome, mainly driven by large waist circumference[^7^](#b7){ref-type="ref"}. In the present study, we confirmed that our findings of cross‐sectional associations were consistent with previous studies on Western populations.

The BMES[^22^](#b22){ref-type="ref"} reported a positive longitudinal association between wider venular caliber at baseline examinations and incidence of obesity. In the present study, however, we did not observe this longitudinal association in a Japanese adult cohort. We have no clear explanation for this discrepancy. One possible explanation is the difference in clinical profile of obesity measures between different races/ethnicities; for example, it has been reported that Asians have a higher body fat percentage even at lower a BMI than Caucasians[^36--38^](#b36 b37 b38){ref-type="ref"}. Other studies reported that the risk of cardiovascular disease or diabetes is increased at lower BMI cut‐offs in Asian populations than in Caucasian populations[^38,39^](#b38 b39){ref-type="ref"}. Thus, the association between wider venular dilation and incident obesity might vary between racial/ethnic groups. Indeed, the mean BMI was 23.9 ± 3.4 kg/m^2^ in the present study, whereas it was 26.1 ± 4.6 kg/m^2^ in BMES. Another possible explanation is that the incidences of obesity and overweight in the present study were relatively low. Also, the 5‐year follow‐up period might have been too short to detect longitudinal associations between retinal vessel caliber and the incidence of obesity in a Japanese population.

Interestingly, we also found a longitudinal association between wider venular dilation and incident obesity in female subjects only. It has been reported that there is a gender difference in the associations between anthropometric indices of obesity and blood pressure[^40^](#b40){ref-type="ref"}, and that BMI might be better than waist circumference for defining metabolic syndrome in Japanese women[^41^](#b41){ref-type="ref"}. The present study suggested that there might be a gender difference in the association of retinal venular change and obesity. Further studies are warranted to investigate whether this gender difference in longitudinal association is because of the difference in the cut‐off for obesity measures between genders or if it is caused by other mechanisms,

Given that we only observed a cross‐sectional association between retinal venodilation and obesity, and there was no longitudinal association, we speculate that retinal venodilation might be secondary to overweight or obesity and not a precedent of developing obesity. The reason for the association between obesity and wider retinal venular caliber is still not fully understood. It is speculated that both obesity and a wider retinal venular caliber share the same risk factors, such as inflammation[^21^](#b21){ref-type="ref"}. An increase in the total blood volume in obese individuals[^42^](#b42){ref-type="ref"} is also considered to cause wider venular caliber[^22^](#b22){ref-type="ref"}.

A key strength of the present study is its standardized assessment of obesity and retinal vessel calibers. The measurement of retinal vessel calibers was carried out at the Fundus Reading Center, Center for Vision Research, University of Melbourne, where BMES grading was also carried out. The present study had several limitations. At baseline examinations, there were differences in clinical characteristics between the included and excluded subjects. The follow‐up rate was 52.9% at the second examination. In addition, there were also differences in clinical characteristics between those subjects who returned for follow up and those who were lost to follow up. Therefore, the study sample might have been influenced by selection bias even after adjustment for characteristics. Second, retinal vessel calibers or measures of obesity were defined based on a single examination. This might have resulted in measurement error, which we assume occurred at random and did not alter the results of our analysis.

In summary, we found that individuals with wider retinal venular caliber were more likely to have central obesity or a high WHR, and our findings confirmed the association reported in Western populations[^8,21--23^](#b8 b21 b22 b23){ref-type="ref"}. However, we could not confirm a longitudinal association between baseline retinal vessel calibers and the 5‐year incidence of obesity. Our findings suggest that retinal venular dilation might share pathophysiology or same risk characteristics as obesity, but it is not predictive of obesity in adult Japanese populations.
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